Cornell Pochily Investment Advisors Inc. reduced its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 7.6% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,773 shares of the biopharmaceutical company’s stock after selling 973 shares during the quarter. Cornell Pochily Investment Advisors […]